December 20, 2014 12:24 AM ET

Capital Markets

Company Overview of Maniv Bioventures LLC

Executive Profile

Robert H. Rubin M.D.

Chief Scientific Advisor, Maniv Bioventures LLC
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Robert H. Rubin, M.D., Ph.D., is the Chief Scientific Advisor at Maniv Bioventures LLC. Dr. Rubin is the Chief of Infectious Disease for Transplantation at Massachusetts General Hospital. Dr. Rubin is a recognized authority in the field of infectious disease and specializes in training physicians and scientists in clinical investigation and experimental pharmacology. He is the Associate Director of the division of infectious disease at Boston's Brigham and Women's ...

Corporate Headquarters

411 State Route 17
Hasbrouck Heights, New Jersey 07604

United States

Phone: 201-727-1411
Fax: --

Board Members Memberships

Former Director

Education

Unknown/Other Education
Williams College
Unknown/Other Education
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Maniv Bioventures LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.